Submissions from 2015
LD Score regression distinguishes confounding from polygenicity in genome-wide association studies, B. K. Bulik-Sullivan, P. R. Loh, H. K. Finucane, S. Ripke, J. Yang, N. Patterson, M. J. Daly, A. L. Price, B. M. Neale, and A. Malhotra
Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk, T. D. Cannon, Y. Chung, G. He, D. Sun, K. Cadenhead, B. A. Cornblatt, M. Tsuang, E. Walker, S. W. Woods, R. Heinssen, and +10 additional authors
A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility, F. D. Carmona, S. L. Mackie, J. E. Martin, J. C. Taylor, A. Vaglio, S. Eyre, L. Bossini-Castillo, S. Castaneda, P. K. Gregersen, G. C. A. Grp Spanish, and +64 additional authors
Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study, J. X. Chen, Y. A. Su, Q. T. Bian, L. H. Wei, R. Z. Zhang, Y. H. Liu, C. Correll, F. D. Yang, S. L. Wang, X. Y. Zhang, and +1 additional author
Changes in body mass and metabolic profiles in patients with first-episode schizophrenia treated for 12 months with a first-generation antipsychotic, B. Chiliza, L. Asmal, P. Oosthuizen, E. Van Niekerk, R. Erasmus, M. Kidd, A. Malhotra, and R. Emsley
A spoonful of sugar helps lymphoma cells go up, N. Chiorazzi
Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic Disorders, Y. Chung, A. Jacobson, G. He, T. G. van Erp, S. McEwen, J. Addington, C. E. Bearden, K. Cadenhead, B. A. Cornblatt, T. D. Cannon, and +8 additional authors
Sepsis: a roadmap for future research, J. Cohen, J. L. Vincent, N. K. Adhikari, F. R. Machado, S. Giulieri, J. Delaloye, S. Opal, K. Tracey, T. van der Poll, E. Pelfrene, and +3 additional authors
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways, H. J. Cordell, Y. Han, G. F. Mells, Y. Li, G. M. Hirschfield, C. S. Greene, G. Xie, B. D. Juran, K. A. Siminovitch, P. Gregersen, and +14 additional authors
Antipsychotic Use in Youth Without Psychosis A Double-edged Sword, C. U. Correll and J. C. Blader
Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder, C. U. Correll, J. Detraux, J. De Lepeleire, and M. De Hert
Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial, C. U. Correll, A. Skuban, J. Ouyang, M. Hobart, S. Pfister, R. D. McQuade, M. Nyilas, W. H. Carson, R. Sanchez, and H. Eriksson
The Glass Is Half Full: Evidence for Efficacy of Alcohol-Wise at One University But Not the Other, K. Croom, L. Staiano-Coico, M. Lesser, D. K. Lewis, V. F. Reyna, T. C. Marchell, J. Frank, and S. Ives
Early intervention services in psychosis: from evidence to wide implementation, C. Csillag, M. Nordentoft, M. Mizuno, P. B. Jones, E. Killackey, M. Taylor, E. Chen, J. M. Kane, and D. McDaid
Predictors of Long-Term Renal Outcome in Lupus Nephritis Trials Lessons Learned from the Euro-Lupus Nephritis Cohort, M. Dall'Era, M. G. Cisternas, D. E. Smilek, L. Straub, F. A. Houssiau, R. Cervera, B. H. Rovin, and M. Mackay
Sustaining the Rheumatology Research Enterprise, A. Davidson and D. Polsky
Attitudes of Psychiatric Nurses about the Request for Euthanasia on the Basis of Unbearable Mental Suffering(UMS), M. De Hert, L. Van Bos, K. Sweers, M. Wampers, J. De Lepeleire, and C. U. Correll
Introduction to immunology at Feinstein Institute for Medical Research (FIMR), B. Diamond and F. Santiago-Schwarz
TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits, D. Diogo, L. Bastarache, K. P. Liao, R. R. Graham, R. S. Fulton, J. D. Greenberg, S. Eyre, A. Lee, P. K. Gregersen, R. M. Plenge, and +44 additional authors
Changes in brain regions associated with food-intake regulation, body mass and metabolic profiles during acute antipsychotic treatment in first-episode schizophrenia, R. Emsley, L. Asmal, B. Chiliza, S. du Plessis, J. Carr, M. Kidd, A. K. Malhotra, M. Vink, and R. S. Kahn
Lithium in the Acute Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study, R. L. Findling, A. Robb, N. K. McNamara, M. N. Pavuluri, V. Kafantaris, R. Scheffer, J. A. Frazier, M. Rynn, M. DelBello, R. A. Kowatch, B. M. Rowles, J. Lingler, K. Martz, R. Anand, T. E. Clemons, and P. Taylor-Zapata
The evolving role of dendritic spines and memory: Interaction(s) with estradiol, M. Frankfurt and V. Luine
Predictors of suicide attempts in 3.322 patients with affective disorders and schizophrenia spectrum disorders, J. A. Gallego, V. Rachamallu, E. Y. Yuen, S. Fink, L. M. Duque, and J. M. Kane
Do antipsychotics increase diabetes risk in children and adolescents?, B. Galling and C. U. Correll
Patient quality of life and pain improve after autologous islet transplantation (AIT) for treatment of chronic pancreatitis: 53 patient series at the University of Arizona, G. Georgiev, M. B. del Rio, A. Gruessner, M. Tiwari, R. Cercone, M. Delbridge, B. Grigsby, R. Gruessner, and H. Rilo
Genome-wide association study of schizophrenia in Ashkenazi Jews, F. S. Goes, J. McGrath, E. E. Kenny, V. Vacic, I. Peters, T. Lencz, A. Darvasi, J. G. Mulle, S. T. Warren, A. E. Pulver, and +5 additional authors
THE AMERICAN SOCIETY OF CLINICAL PSYCHOPHARMACOLOGY SURVEY OF PSYCHOPHARMACOLOGISTS' PRACTICE PATTERNS FOR THE TREATMENT OF MOOD DISORDERS, J. F. Goldberg, M. P. Freeman, R. Balon, L. Citrome, M. E. Thase, J. M. Kane, and M. Fava
Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer's disease randomized controlled trials, T. E. Goldberg, P. D. Harvey, K. A. Wesnes, P. J. Snyder, and L. S. Schneider
Patient selection in congenital pyriform aperture stenosis repair-14 year experience and systematic review of literature, N. J. Gonik, J. Cheng, M. Lesser, M. J. Shikowitz, and L. P. Smith
Insomnia in Adults With Chronic Hepatitis B, Liver Failure, and Cirrhosis: A Case-Control Study, H. M. Guo, M. Liu, Y. T. Xiang, J. Zhao, G. S. Ungvari, C. U. Correll, C. H. Ng, H. F. Chiu, and Z. P. Duan
Measurement-Based Care Versus Standard Care for Major Depression: A Randomized Controlled Trial With Blind Raters, T. Guo, Y. T. Xiang, L. Xiao, C. Q. Hu, H. F. Chiu, G. S. Ungvari, C. U. Correll, K. Y. Lai, L. Feng, Y. Geng, Y. Feng, and G. Wang
Ambiguous findings concerning potential advantages of depot antipsychotics: in search of clinical relevance, P. M. Haddad, T. Kishimoto, C. U. Correll, and J. M. Kane
Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study, J. G. Hanly, L. Su, M. B. Urowitz, J. Romero-Diaz, C. Gordon, S. C. Bae, S. Bernatsky, A. E. Clarke, C. Aranow, V. Farewell, and +32 additional authors
Cholinergic anti-inflammatory pathway activity in dialysis patients: a role for neuroimmunomodulation?, M. Hilderman, A. R. Qureshi, Y. Al-Abed, F. Abtahi, K. Lindecrantz, B. Anderstam, and A. Bruchfeld
DNA-Containing Immunocomplexes Promote Inflammasome Assembly and Release of Pyrogenic Cytokines by CD14+ CD16+ CD64high CD32low Inflammatory Monocytes from Malaria Patients, I. C. Hirako, C. Gallego-Marin, M. A. Ataide, W. A. Andrade, H. Gravina, B. C. Rocha, R. B. de Oliveira, D. B. Pereira, B. Diamond, R. T. Gazzinelli, and +3 additional authors
Genome-wide autozygosity is associated with lower general cognitive ability, D. P. Howrigan, M. A. Simonson, G. Davies, S. E. Harris, A. Tenesa, J. M. Starr, D. C. Liewald, D. I. Boomsma, P. DeRosse, M. C. Keller, and +37 additional authors
Haloperidol and sudden cardiac death in dementia: autopsy findings in psychiatric inpatients, P. Ifteni, E. Grudnikoff, J. Koppel, Neil Kremen, C. U. Correll, J. M. Kane, and Peter Manu
Subcortical modulation in auditory processing and auditory hallucinations, T. Ikuta, P. DeRosse, M. Argyelan, K. H. Karlsgodt, P. B. Kingsley, P. R. Szeszko, and A. K. Malhotra
Corrected QT Changes During Antipsychotic Treatment of Children and Adolescents: A Systematic Review and Meta-Analysis of Clinical Trials, K. G. Jensen, K. Juul, A. Fink-Jensen, C. U. Correll, and A. K. Pagsberg
Oxidative Stress and Antioxidant Parameters in Patients With Major Depressive Disorder Compared to Healthy Controls Before and After Antidepressant Treatment: Results From a Meta-Analysis, S. Jimenez-Fernandez, M. Gurpegui, F. Diaz-Atienza, L. Perez-Costillas, M. Gerstenberg, and C. U. Correll
Pharmacological inhibition of MIF interferes with trophoblast cell migration and invasiveness, M. Jovanovic Krivokuca, I. Stefanoska, T. Abu Rabi, Y. Al-Abed, S. Stosic-Grujicic, and Lj Vicovac
Schizophrenia, R. S. Kahn, I. E. Sommer, R. M. Murray, A. Meyer-Lindenberg, D. R. Weinberger, T. D. Cannon, M. O'Donovan, C. U. Correll, J. M. Kane, T. R. Insel, and +1 additional author
Subcutaneous injections of low doses of humanized anti-CD20 veltuzumab: A phase I study in chronic lymphocytic leukemia, M. E. Kalaycio, O. G. Negrea, S. L. Allen, K. R. Rai, R. M. Abbasi, H. Horne, W. A. Wegener, and D. M. Goldenberg
The role of NMDA receptors in schizophrenia, J. M. Kane
A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia, J. M. Kane, A. Skuban, J. Ouyang, M. Hobart, S. Pfister, R. D. McQuade, M. Nyilas, W. H. Carson, R. Sanchez, and H. Eriksson
Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia: Results From an International, Phase III Clinical Trial, J. M. Kane, S. Zukin, Y. Wang, K. Lu, A. Ruth, K. Nagy, I. Laszlovszky, and S. Durgam
D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial, J. T. Kantrowitz, S. W. Woods, E. Petkova, B. A. Cornblatt, C. M. Corcoran, H. Chen, G. Silipo, and D. C. Javitt
Interactions between Plasmodium falciparum skeleton-binding protein 1 and the membrane skeleton of malaria-infected red blood cells, L. M. Kats, N. I. Proellocks, D. W. Buckingham, L. Blanc, J. Hale, X. Guo, X. Pei, S. Herrmann, E. G. Hanssen, B. M. Cooke, and +3 additional authors
More data on speed of remission with ECT in geriatric depression, C. H. Kellner, E. T. Geduldig, R. D. Weiner, R. M. Greenberg, J. Prudic, W. V. McCall, G. Petrides, M. M. Husain, M. V. Rudorfer, S. H. Lisanby, and +2 additional authors
Bioprinting Complex Cartilaginous Structures with Clinically Compliant Biomaterials, M. Kesti, C. Eberhardt, G. Pagliccia, D. Kenkel, D. Grande, A. Boss, and M. Zenobi-Wong
High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci, K. Kim, S. Y. Bang, H. S. Lee, S. K. Cho, C. B. Choi, Y. K. Sung, T. H. Kim, P. K. Gregersen, S. C. Bae, and +32 additional authors
Immunological function of Blimp-1 in dendritic cells and relevance to autoimmune diseases, S. J. Kim
Robotics: A Rehabilitation Modality, H. I. Krebs and B. T. Volpe
[Should antipsychotics be used in prodromal stages of schizophrenia to prevent psychosis? Pro], M. Lambert and C. U. Correll
Apolipoprotein L1 (APOL1) Variants (Vs) a possible link between Heroin-associated Nephropathy (HAN) and HIV-associated Nephropathy (HIVAN), X. Lan, T. K. Rao, P. N. Chander, K. Skorecki, and P. C. Singhal
New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis, S. H. Lee, T. Lencz, A. K. Malhotra, H. Medeiros, V. Milanova, J. Shi, P. Sklar, P. K. Gregersen, M. van Laar, P. van Riel, and +134 additional authors
Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases, T. Lencz, A. J. Deutsch, B. Han, X. Hu, Y. Okada, S. Eyre, M. Knapp, A. Zhernakova, P. K. Gregersen, S. Raychaudhuri, and +27 additional authors
Targeting the schizophrenia genome: a fast track strategy from GWAS to clinic, T. Lencz and A. K. Malhotra
Services on early recognition of psychoses and bipolar disorders in Germany, K. Leopold, A. Nikolaides, M. Bauer, A. Bechdolf, C. U. Correll, F. Jessen, J. Klosterkotter, S. Ruhrmann, S. Pfeiffer, A. Pfennig, and +3 additional authors
ITI-007 for the Treatment of Schizophrenia: A 4-Week Randomized, Double-Blind, Controlled Trial, J. A. Lieberman, R. E. Davis, C. U. Correll, D. C. Goff, J. M. Kane, C. A. Tamminga, S. Mates, and K. E. Vanover
Curing sickle cell disease: Mission accomplished?, J. M. Lipton
In memoriam: Robert J. Arceci, J. M. Lipton and P. E. Newburger
Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: Findings of the third national survey on use of psychotropic medications in China, Q. Li, Y. T. Xiang, Y. A. Su, L. Shu, X. Yu, H. F. Chiu, Christoph Correll, G. S. Ungvari, K. Y. Lai, T. M. Si, and +9 additional authors
Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012), Q. Li, Y. T. Xiang, Y. A. Su, L. Shu, X. Yu, C. U. Correll, Q. Y. Mei, K. Q. Li, T. M. Si, J. M. Kane, and +9 additional authors
Common variants of IRF3 conferring risk of schizophrenia, X. Li, W. Zhang, T. Lencz, A. Darvasi, A. Alkelai, D. F. Zhang, L. Yu, X. F. Xu, M. Li, Y. G. Yao, and +2 additional authors
Treatment of early non-response in patients with schizophrenia: assessing the efficacy of antipsychotic dose escalation, A. Loebel, L. Citrome, C. U. Correll, J. Xu, J. Cucchiaro, and J. M. Kane
Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis, C. Luchini, N. Veronese, M. Solmi, H. Cho, J. H. Kim, S. Kyo, S. Y. Lee, D. W. Kim, G. M. Yousef, C. U. Correll, and +22 additional authors
Introduction to the Special Issue Estradiol and Cognition: Molecules to Mind, V. Luine and M. Frankfurt
TAT-HSP70 ATTENUATES EXPERIMENTAL LUNG INJURY, M. M. Lyons, N. N. Raj, J. L. Chittams, L. Kilpatrick, and C. S. Deutschman
Joint analysis of psychiatric disorders increases accuracy of risk prediction for schizophrenia, bipolar disorder, and major depressive disorder, R. Maier, G. Moser, C. M. Hultman, M. Landen, D. F. Levinson, K. S. Kendler, J. W. Smoller, N. R. Wray, S. H. Lee, T. Lencz, and +7 additional authors
Dissecting the Heterogeneity of Treatment Response in First-Episode Schizophrenia, A. K. Malhotra
Studies on ageing and the severity of radiographic joint damage in rheumatoid arthritis, L. Mangnus, H. W. van Steenbergen, E. Lindqvist, E. Brouwer, M. Reijnierse, T. W. Huizinga, P. K. Gregersen, E. Berglin, S. Rantapaa-Dahlqvist, A. H. van der Helm-van Mil, and +1 additional author
Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management, P. Manu, L. Dima, M. Shulman, D. Vancampfort, M. De Hert, and C. U. Correll
IL-10 restricts dendritic cell (DC) growth at the monocyte-to-monocyte-derived DC interface by disrupting anti-apoptotic and cytoprotective autophagic molecular machinery, C. Martin, M. P. Espaillat, and F. Santiago-Schwarz
Could the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR) be used in depressed schizophrenia patients?, X. R. Ma, Y. Q. Lin, Y. Li, H. F. K. Chiu, G. S. Ungvari, C. U. Correll, K. Y. C. Lai, M. Y. Cai, J. Yun, Y. T. Xiang, and +5 additional authors
Anxiety in youth at clinical high risk for psychosis, L. McAusland, L. Buchy, K. S. Cadenhead, T. D. Cannon, B. A. Cornblatt, E. F. Walker, S. W. Woods, C. E. Bearden, D. H. Mathalon, J. Addington, and +5 additional authors
Clinical and functional outcomes after 2 years in the early detection and intervention for the prevention of psychosis multisite effectiveness trial, W. R. McFarlane, B. Levin, L. Travis, F. L. Lucas, S. Lynch, M. Verdi, Barbara Cornblatt, S. F. Taylor, A. M. Auther, E. Spring, and +11 additional authors
Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes, F. W. Miller, W. Chen, T. P. O'Hanlon, R. G. Cooper, J. Vencovsky, L. G. Rider, K. Danko, A. Lee, P. K. Gregersen, C. I. Amos, and +17 additional authors
Predictors of resolution and persistence of renal laboratory abnormalities in pediatric HIV infection, C. D. Mitchell; M. C. Chernoff; G. R., 3rd Seage; M. U. Purswani; H. M. Spiegel; G. Zilleruelo; C. Abitbol; B. Heckman; J. M. Oleske; V. Bonagura; and IMPAACT 219/219C Study Team
The NAVIGATE Program for First-Episode Psychosis: Rationale, Overview, and Description of Psychosocial Components, K. T. Mueser, D. L. Penn, P. Meyer-Kalos, S. R. McGurk, C. Cather, S. Saade, D. G. Robinson, N. R. Schooler, R. A. Rosenheck, J. M. Kane, and +6 additional authors
Disease-Free Survival According to the Use of Postmastectomy Radiation Therapy After Neoadjuvant Chemotherapy, H. Nagar, D. Boothe, P. S. Ginter, C. Sison, L. Vahdat, S. Shin, M. Smith, K. S. C. Chao, D. Nori, and M. K. Hayes
A Stationary Wavelet Entropy-Based Clustering Approach Accurately Predicts Gene Expression, N. Nguyen, A. Vo, I. Choi, and K. J. Won
Revisiting the Discussion: Termination of Clozapine Treatment Due to Renal Failure Reply, J. Nielsen, P. Manu, J. M. Kane, and C. U. Correll
Clinical characteristics and influence of childhood trauma on the prodrome of bipolar disorder, M. N. Noto, C. Noto, A. C. Caribe, A. Miranda-Scippa, S. O. Nunes, A. C. Chaves, D. Amino, R. Grassi-Oliveira, C. U. Correll, and E. Brietzke
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways, C. O'Dushlaine, C. Betancur, S. Herms, R. Krasucki, M. Leboyer, D. H. Ledbetter, T. Lencz, A. K. Malhotra, J. W. Smoller, P. A. Holmans, and +365 additional authors
Anti-C1q antibodies in systemic lupus erythematosus, A. M. Orbai, L. Truedsson, G. Sturfelt, O. Nived, H. Fang, G. S. Alarcon, C. Gordon, J. Merrill, C. Aranow, M. Petri, and +43 additional authors
Objective identification and analysis of physiological and behavioral signs of schizophrenia, M. Osipov, Y. Behzadi, J. M. Kane, G. Petrides, and G. D. Clifford
PANSS-6: a brief rating scale for the measurement of severity in schizophrenia, S. D. Ostergaard, O. M. Lemming, O. Mors, C. U. Correll, and P. Bech
Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort, B. Parker, M. B. Urowitz, D. D. Gladman, M. Lunt, R. Donn, S. C. Bae, J. Sanchez-Guerrero, C. Aranow, M. Mackay, I. N. Bruce, and +30 additional authors
Delayed identification and diagnosis of Huntington's disease due to psychiatric symptoms, A. M. Pascu, P. Ifteni, A. Teodorescu, V. Burtea, and C. U. Correll
Neural circuitry and immunity, V. Pavlov and K. J. Tracey
Severity of thought disorder predicts psychosis in persons at clinical high-risk, D. O. Perkins, C. D. Jeffries, B. A. Cornblatt, S. W. Woods, J. Addington, D. H. Mathalon, L. J. Seidman, M. T. Tsuang, E. F. Walker, T. H. McGlashan, and +4 additional authors
Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives, A. M. Persico, C. Arango, J. K. Buitelaar, C. U. Correll, J. C. Glennon, P. J. Hoekstra, C. Moreno, B. Vitiello, J. Vorstman, and A. Zuddas
Establishing a translational genomics infrastructure in pediatric cancer: the GREAT KIDS experience, N. Pinto, S. L. Volchenboum, A. D. Skol, L. Rhodes, A. Doan, C. Fein-Levy, J. M. Lipton, J. M. Cunningham, and K. Onel
Early stages of bipolar disorder: characterization and strategies for early intervention, A. C. Rios; M. N. Noto; L. B. Rizzo; R. Mansur; F. E., Jr. Martins; R. Grassi-Oliveira; C. U. Correll; and E. Brietzke
Sudden Cardiac Death in Young Adults With Previous Hospital-Based Psychiatric Inpatient and Outpatient Treatment: A Nationwide Cohort Study From Denmark, B. Risgaard, K. Waagstein, R. Jabbari, T. H. Lynge, C. Glinge, C. Albert, C. U. Correll, S. Haunso, A. Fink-Jensen, J. Tfelt-Hansen, and +1 additional author
Child and Adolescent Psychiatrists' Reported Monitoring Behaviors for Second-Generation Antipsychotics, A. M. Rodday, S. K. Parsons, C. Mankiw, C. U. Correll, A. S. Robb, B. T. Zima, T. S. Saunders, and L. K. Leslie
Maintenance Electroconvulsive Therapy: Cost-effectiveness and Patient/Family Satisfaction, R. Rodriguez-Jimenez, A. Bagney, I. Torio, M. Caballero, P. Ruiz, F. P. Rivas-Clemente, M. A. Jimenez-Arriero, and G. Petrides